Retrospective 2023 : Medical Innovation

Dear colleague, 

Once again, we wish you an excellent 2024!

For Cerba, 2023 was a dynamic year full of challenges:

Medical innovation at the service of your patients

In 2023, an ever-expanding range of tests to support you in your day-to-day work and open up new diagnostic and management perspectives for your patients.


 Medical Genetics


Optical mapping, a new-generation post-natal cytogenetic diagnostic test


+ More than 150 gene panels in our catalogue
14 medical specialities


Development of custom panels


HLA typing by NGS






Arbovirosis triplex PCR

Onco-hématologie.png  Onco-haematology

Multiple myeloma NGS panel (175 genes)


 Neurologie.png  Neurology


Dosage of 2nd generation anti-depressants


  Endocrinologie.png  Endocrinology


Endocrine disruptors: phthalates and bisphenols panels

  Oncologie.png Oncology


HRD by Shallow Whole Genome Sequencing (sWGS)

Cholangiocarcinoma panel

Pancreas panel (BRCA1, BRCA2 and KRAS)

Large Oncosomatic Panel (634 genes) (Clinical trials)


The Cerba International Customer Service Team